Nutrition & Metabolism-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=561624, encodeId=ced356162431, content=氧化应激150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, beContent=150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Mon Oct 01 00:00:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561469, encodeId=66c356146980, content=你好，你写的是哪方面的内容150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～150****6990 2018-08-25 00:00:00 发表: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f80b1635617, createdName=1dd92ec0m26(暂无匿称), createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560443, encodeId=01c6560443e8, content=6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Sat Aug 25 00:00:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554917, encodeId=c77955491efc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2017年6月27号投稿 投的2型糖尿病方面的meta分析 2017年8月16号小修 2017年9月3号修回，18号接受，历时不到3个月。 总体来说，不难，升3分以上有难度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Sx9eFkIoYXS51HXxUcZoVsNzMFRK6sPjs4WW9QTp0aQJy4wszSAUHrPPBZ3zu8cGBZ1A5uoN4HMS4xYu55VfQ/132, createdBy=a55e2060721, createdName=sherry me, createdTime=Thu Apr 12 21:51:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547968, encodeId=382354e96815, content=请问大神们，版面费的情况？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Fri Oct 06 21:45:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538975, encodeId=777e5389e55f, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531433, encodeId=da045314331e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：非常幸运，由于准备比较充分，研究内容很切合杂志要求，所以投稿比较顺利。11.3号投稿后，12.8号修回，12.20号返修后1周接收。在2016年年底接收，算是为自己一年的努力画上了一个圆满的小句号。感悟：投稿前认真分析杂志的需求，文稿一定要认真修改好再投，当然审稿人没有提太多苛刻的问题也是一个重要的因素。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20ef96448, createdName=haoyaxin, createdTime=Wed Jan 04 17:02:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492604, encodeId=c581492604cd, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491572, encodeId=aedb4915e283, content=还有谁投过，上来讲讲啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 22 09:08:00 CST 2012, time=2012-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487907, encodeId=c9ff48e9075b, content=审稿比较快！3月22日投稿后即显示under review，4月4号送审，4月11号告知被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee9f60163, createdName=wanglijun519, createdTime=Wed Apr 11 11:14:00 CST 2012, time=2012-04-11, status=1, ipAttribution=)]

2018-10-01 1501ef7333m

氧化应激150****7326(暂无匿称) 2018-09-26 00:00:00 发表:
你好，你写的是哪方面的内容

150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容

363 0

[GetPortalCommentsPageByObjectIdResponse(id=561624, encodeId=ced356162431, content=氧化应激150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, beContent=150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Mon Oct 01 00:00:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561469, encodeId=66c356146980, content=你好，你写的是哪方面的内容150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～150****6990 2018-08-25 00:00:00 发表: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f80b1635617, createdName=1dd92ec0m26(暂无匿称), createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560443, encodeId=01c6560443e8, content=6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Sat Aug 25 00:00:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554917, encodeId=c77955491efc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2017年6月27号投稿 投的2型糖尿病方面的meta分析 2017年8月16号小修 2017年9月3号修回，18号接受，历时不到3个月。 总体来说，不难，升3分以上有难度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Sx9eFkIoYXS51HXxUcZoVsNzMFRK6sPjs4WW9QTp0aQJy4wszSAUHrPPBZ3zu8cGBZ1A5uoN4HMS4xYu55VfQ/132, createdBy=a55e2060721, createdName=sherry me, createdTime=Thu Apr 12 21:51:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547968, encodeId=382354e96815, content=请问大神们，版面费的情况？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Fri Oct 06 21:45:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538975, encodeId=777e5389e55f, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531433, encodeId=da045314331e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：非常幸运，由于准备比较充分，研究内容很切合杂志要求，所以投稿比较顺利。11.3号投稿后，12.8号修回，12.20号返修后1周接收。在2016年年底接收，算是为自己一年的努力画上了一个圆满的小句号。感悟：投稿前认真分析杂志的需求，文稿一定要认真修改好再投，当然审稿人没有提太多苛刻的问题也是一个重要的因素。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20ef96448, createdName=haoyaxin, createdTime=Wed Jan 04 17:02:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492604, encodeId=c581492604cd, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491572, encodeId=aedb4915e283, content=还有谁投过，上来讲讲啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 22 09:08:00 CST 2012, time=2012-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487907, encodeId=c9ff48e9075b, content=审稿比较快！3月22日投稿后即显示under review，4月4号送审，4月11号告知被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee9f60163, createdName=wanglijun519, createdTime=Wed Apr 11 11:14:00 CST 2012, time=2012-04-11, status=1, ipAttribution=)]

2018-09-26 1dd92ec0m26(暂无匿称)

你好，你写的是哪方面的内容150****6990 2018-08-25 发表::
6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～150****6990 2018-08-25 00:00:00 发表:
6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～

150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～

317 0

[GetPortalCommentsPageByObjectIdResponse(id=561624, encodeId=ced356162431, content=氧化应激150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, beContent=150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Mon Oct 01 00:00:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561469, encodeId=66c356146980, content=你好，你写的是哪方面的内容150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～150****6990 2018-08-25 00:00:00 发表: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f80b1635617, createdName=1dd92ec0m26(暂无匿称), createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560443, encodeId=01c6560443e8, content=6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Sat Aug 25 00:00:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554917, encodeId=c77955491efc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2017年6月27号投稿 投的2型糖尿病方面的meta分析 2017年8月16号小修 2017年9月3号修回，18号接受，历时不到3个月。 总体来说，不难，升3分以上有难度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Sx9eFkIoYXS51HXxUcZoVsNzMFRK6sPjs4WW9QTp0aQJy4wszSAUHrPPBZ3zu8cGBZ1A5uoN4HMS4xYu55VfQ/132, createdBy=a55e2060721, createdName=sherry me, createdTime=Thu Apr 12 21:51:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547968, encodeId=382354e96815, content=请问大神们，版面费的情况？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Fri Oct 06 21:45:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538975, encodeId=777e5389e55f, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531433, encodeId=da045314331e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：非常幸运，由于准备比较充分，研究内容很切合杂志要求，所以投稿比较顺利。11.3号投稿后，12.8号修回，12.20号返修后1周接收。在2016年年底接收，算是为自己一年的努力画上了一个圆满的小句号。感悟：投稿前认真分析杂志的需求，文稿一定要认真修改好再投，当然审稿人没有提太多苛刻的问题也是一个重要的因素。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20ef96448, createdName=haoyaxin, createdTime=Wed Jan 04 17:02:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492604, encodeId=c581492604cd, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491572, encodeId=aedb4915e283, content=还有谁投过，上来讲讲啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 22 09:08:00 CST 2012, time=2012-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487907, encodeId=c9ff48e9075b, content=审稿比较快！3月22日投稿后即显示under review，4月4号送审，4月11号告知被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee9f60163, createdName=wanglijun519, createdTime=Wed Apr 11 11:14:00 CST 2012, time=2012-04-11, status=1, ipAttribution=)]

2018-08-25 1501ef7333m

6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～

353 0

[GetPortalCommentsPageByObjectIdResponse(id=561624, encodeId=ced356162431, content=氧化应激150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, beContent=150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Mon Oct 01 00:00:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561469, encodeId=66c356146980, content=你好，你写的是哪方面的内容150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～150****6990 2018-08-25 00:00:00 发表: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f80b1635617, createdName=1dd92ec0m26(暂无匿称), createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560443, encodeId=01c6560443e8, content=6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Sat Aug 25 00:00:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554917, encodeId=c77955491efc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2017年6月27号投稿 投的2型糖尿病方面的meta分析 2017年8月16号小修 2017年9月3号修回，18号接受，历时不到3个月。 总体来说，不难，升3分以上有难度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Sx9eFkIoYXS51HXxUcZoVsNzMFRK6sPjs4WW9QTp0aQJy4wszSAUHrPPBZ3zu8cGBZ1A5uoN4HMS4xYu55VfQ/132, createdBy=a55e2060721, createdName=sherry me, createdTime=Thu Apr 12 21:51:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547968, encodeId=382354e96815, content=请问大神们，版面费的情况？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Fri Oct 06 21:45:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538975, encodeId=777e5389e55f, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531433, encodeId=da045314331e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：非常幸运，由于准备比较充分，研究内容很切合杂志要求，所以投稿比较顺利。11.3号投稿后，12.8号修回，12.20号返修后1周接收。在2016年年底接收，算是为自己一年的努力画上了一个圆满的小句号。感悟：投稿前认真分析杂志的需求，文稿一定要认真修改好再投，当然审稿人没有提太多苛刻的问题也是一个重要的因素。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20ef96448, createdName=haoyaxin, createdTime=Wed Jan 04 17:02:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492604, encodeId=c581492604cd, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491572, encodeId=aedb4915e283, content=还有谁投过，上来讲讲啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 22 09:08:00 CST 2012, time=2012-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487907, encodeId=c9ff48e9075b, content=审稿比较快！3月22日投稿后即显示under review，4月4号送审，4月11号告知被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee9f60163, createdName=wanglijun519, createdTime=Wed Apr 11 11:14:00 CST 2012, time=2012-04-11, status=1, ipAttribution=)]

2018-04-12 sherry me

审稿速度:1.0 | 投稿命中率:50.0
经验分享：2017年6月27号投稿
投的2型糖尿病方面的meta分析
2017年8月16号小修
2017年9月3号修回，18号接受，历时不到3个月。
总体来说，不难，升3分以上有难度。

377 0

[GetPortalCommentsPageByObjectIdResponse(id=561624, encodeId=ced356162431, content=氧化应激150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, beContent=150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Mon Oct 01 00:00:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561469, encodeId=66c356146980, content=你好，你写的是哪方面的内容150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～150****6990 2018-08-25 00:00:00 发表: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f80b1635617, createdName=1dd92ec0m26(暂无匿称), createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560443, encodeId=01c6560443e8, content=6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Sat Aug 25 00:00:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554917, encodeId=c77955491efc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2017年6月27号投稿 投的2型糖尿病方面的meta分析 2017年8月16号小修 2017年9月3号修回，18号接受，历时不到3个月。 总体来说，不难，升3分以上有难度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Sx9eFkIoYXS51HXxUcZoVsNzMFRK6sPjs4WW9QTp0aQJy4wszSAUHrPPBZ3zu8cGBZ1A5uoN4HMS4xYu55VfQ/132, createdBy=a55e2060721, createdName=sherry me, createdTime=Thu Apr 12 21:51:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547968, encodeId=382354e96815, content=请问大神们，版面费的情况？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Fri Oct 06 21:45:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538975, encodeId=777e5389e55f, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531433, encodeId=da045314331e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：非常幸运，由于准备比较充分，研究内容很切合杂志要求，所以投稿比较顺利。11.3号投稿后，12.8号修回，12.20号返修后1周接收。在2016年年底接收，算是为自己一年的努力画上了一个圆满的小句号。感悟：投稿前认真分析杂志的需求，文稿一定要认真修改好再投，当然审稿人没有提太多苛刻的问题也是一个重要的因素。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20ef96448, createdName=haoyaxin, createdTime=Wed Jan 04 17:02:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492604, encodeId=c581492604cd, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491572, encodeId=aedb4915e283, content=还有谁投过，上来讲讲啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 22 09:08:00 CST 2012, time=2012-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487907, encodeId=c9ff48e9075b, content=审稿比较快！3月22日投稿后即显示under review，4月4号送审，4月11号告知被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee9f60163, createdName=wanglijun519, createdTime=Wed Apr 11 11:14:00 CST 2012, time=2012-04-11, status=1, ipAttribution=)]

2017-10-06 sesee

请问大神们，版面费的情况？？

299 0

[GetPortalCommentsPageByObjectIdResponse(id=561624, encodeId=ced356162431, content=氧化应激150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, beContent=150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Mon Oct 01 00:00:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561469, encodeId=66c356146980, content=你好，你写的是哪方面的内容150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～150****6990 2018-08-25 00:00:00 发表: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f80b1635617, createdName=1dd92ec0m26(暂无匿称), createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560443, encodeId=01c6560443e8, content=6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Sat Aug 25 00:00:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554917, encodeId=c77955491efc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2017年6月27号投稿 投的2型糖尿病方面的meta分析 2017年8月16号小修 2017年9月3号修回，18号接受，历时不到3个月。 总体来说，不难，升3分以上有难度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Sx9eFkIoYXS51HXxUcZoVsNzMFRK6sPjs4WW9QTp0aQJy4wszSAUHrPPBZ3zu8cGBZ1A5uoN4HMS4xYu55VfQ/132, createdBy=a55e2060721, createdName=sherry me, createdTime=Thu Apr 12 21:51:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547968, encodeId=382354e96815, content=请问大神们，版面费的情况？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Fri Oct 06 21:45:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538975, encodeId=777e5389e55f, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531433, encodeId=da045314331e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：非常幸运，由于准备比较充分，研究内容很切合杂志要求，所以投稿比较顺利。11.3号投稿后，12.8号修回，12.20号返修后1周接收。在2016年年底接收，算是为自己一年的努力画上了一个圆满的小句号。感悟：投稿前认真分析杂志的需求，文稿一定要认真修改好再投，当然审稿人没有提太多苛刻的问题也是一个重要的因素。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20ef96448, createdName=haoyaxin, createdTime=Wed Jan 04 17:02:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492604, encodeId=c581492604cd, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491572, encodeId=aedb4915e283, content=还有谁投过，上来讲讲啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 22 09:08:00 CST 2012, time=2012-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487907, encodeId=c9ff48e9075b, content=审稿比较快！3月22日投稿后即显示under review，4月4号送审，4月11号告知被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee9f60163, createdName=wanglijun519, createdTime=Wed Apr 11 11:14:00 CST 2012, time=2012-04-11, status=1, ipAttribution=)]

2017-07-18 med_wu

过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。

305 0

[GetPortalCommentsPageByObjectIdResponse(id=561624, encodeId=ced356162431, content=氧化应激150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, beContent=150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Mon Oct 01 00:00:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561469, encodeId=66c356146980, content=你好，你写的是哪方面的内容150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～150****6990 2018-08-25 00:00:00 发表: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f80b1635617, createdName=1dd92ec0m26(暂无匿称), createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560443, encodeId=01c6560443e8, content=6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Sat Aug 25 00:00:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554917, encodeId=c77955491efc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2017年6月27号投稿 投的2型糖尿病方面的meta分析 2017年8月16号小修 2017年9月3号修回，18号接受，历时不到3个月。 总体来说，不难，升3分以上有难度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Sx9eFkIoYXS51HXxUcZoVsNzMFRK6sPjs4WW9QTp0aQJy4wszSAUHrPPBZ3zu8cGBZ1A5uoN4HMS4xYu55VfQ/132, createdBy=a55e2060721, createdName=sherry me, createdTime=Thu Apr 12 21:51:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547968, encodeId=382354e96815, content=请问大神们，版面费的情况？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Fri Oct 06 21:45:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538975, encodeId=777e5389e55f, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531433, encodeId=da045314331e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：非常幸运，由于准备比较充分，研究内容很切合杂志要求，所以投稿比较顺利。11.3号投稿后，12.8号修回，12.20号返修后1周接收。在2016年年底接收，算是为自己一年的努力画上了一个圆满的小句号。感悟：投稿前认真分析杂志的需求，文稿一定要认真修改好再投，当然审稿人没有提太多苛刻的问题也是一个重要的因素。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20ef96448, createdName=haoyaxin, createdTime=Wed Jan 04 17:02:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492604, encodeId=c581492604cd, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491572, encodeId=aedb4915e283, content=还有谁投过，上来讲讲啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 22 09:08:00 CST 2012, time=2012-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487907, encodeId=c9ff48e9075b, content=审稿比较快！3月22日投稿后即显示under review，4月4号送审，4月11号告知被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee9f60163, createdName=wanglijun519, createdTime=Wed Apr 11 11:14:00 CST 2012, time=2012-04-11, status=1, ipAttribution=)]

2017-01-04 haoyaxin

审稿速度:2.0 | 投稿命中率:50.0
经验分享：非常幸运，由于准备比较充分，研究内容很切合杂志要求，所以投稿比较顺利。11.3号投稿后，12.8号修回，12.20号返修后1周接收。在2016年年底接收，算是为自己一年的努力画上了一个圆满的小句号。感悟：投稿前认真分析杂志的需求，文稿一定要认真修改好再投，当然审稿人没有提太多苛刻的问题也是一个重要的因素。

356 0

[GetPortalCommentsPageByObjectIdResponse(id=561624, encodeId=ced356162431, content=氧化应激150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, beContent=150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Mon Oct 01 00:00:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561469, encodeId=66c356146980, content=你好，你写的是哪方面的内容150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～150****6990 2018-08-25 00:00:00 发表: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f80b1635617, createdName=1dd92ec0m26(暂无匿称), createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560443, encodeId=01c6560443e8, content=6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Sat Aug 25 00:00:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554917, encodeId=c77955491efc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2017年6月27号投稿 投的2型糖尿病方面的meta分析 2017年8月16号小修 2017年9月3号修回，18号接受，历时不到3个月。 总体来说，不难，升3分以上有难度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Sx9eFkIoYXS51HXxUcZoVsNzMFRK6sPjs4WW9QTp0aQJy4wszSAUHrPPBZ3zu8cGBZ1A5uoN4HMS4xYu55VfQ/132, createdBy=a55e2060721, createdName=sherry me, createdTime=Thu Apr 12 21:51:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547968, encodeId=382354e96815, content=请问大神们，版面费的情况？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Fri Oct 06 21:45:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538975, encodeId=777e5389e55f, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531433, encodeId=da045314331e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：非常幸运，由于准备比较充分，研究内容很切合杂志要求，所以投稿比较顺利。11.3号投稿后，12.8号修回，12.20号返修后1周接收。在2016年年底接收，算是为自己一年的努力画上了一个圆满的小句号。感悟：投稿前认真分析杂志的需求，文稿一定要认真修改好再投，当然审稿人没有提太多苛刻的问题也是一个重要的因素。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20ef96448, createdName=haoyaxin, createdTime=Wed Jan 04 17:02:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492604, encodeId=c581492604cd, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491572, encodeId=aedb4915e283, content=还有谁投过，上来讲讲啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 22 09:08:00 CST 2012, time=2012-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487907, encodeId=c9ff48e9075b, content=审稿比较快！3月22日投稿后即显示under review，4月4号送审，4月11号告知被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee9f60163, createdName=wanglijun519, createdTime=Wed Apr 11 11:14:00 CST 2012, time=2012-04-11, status=1, ipAttribution=)]

2012-11-28 qupeter

明年能不能冲到3分？大家谈谈

382 0

[GetPortalCommentsPageByObjectIdResponse(id=561624, encodeId=ced356162431, content=氧化应激150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, beContent=150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Mon Oct 01 00:00:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561469, encodeId=66c356146980, content=你好，你写的是哪方面的内容150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～150****6990 2018-08-25 00:00:00 发表: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f80b1635617, createdName=1dd92ec0m26(暂无匿称), createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560443, encodeId=01c6560443e8, content=6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Sat Aug 25 00:00:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554917, encodeId=c77955491efc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2017年6月27号投稿 投的2型糖尿病方面的meta分析 2017年8月16号小修 2017年9月3号修回，18号接受，历时不到3个月。 总体来说，不难，升3分以上有难度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Sx9eFkIoYXS51HXxUcZoVsNzMFRK6sPjs4WW9QTp0aQJy4wszSAUHrPPBZ3zu8cGBZ1A5uoN4HMS4xYu55VfQ/132, createdBy=a55e2060721, createdName=sherry me, createdTime=Thu Apr 12 21:51:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547968, encodeId=382354e96815, content=请问大神们，版面费的情况？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Fri Oct 06 21:45:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538975, encodeId=777e5389e55f, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531433, encodeId=da045314331e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：非常幸运，由于准备比较充分，研究内容很切合杂志要求，所以投稿比较顺利。11.3号投稿后，12.8号修回，12.20号返修后1周接收。在2016年年底接收，算是为自己一年的努力画上了一个圆满的小句号。感悟：投稿前认真分析杂志的需求，文稿一定要认真修改好再投，当然审稿人没有提太多苛刻的问题也是一个重要的因素。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20ef96448, createdName=haoyaxin, createdTime=Wed Jan 04 17:02:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492604, encodeId=c581492604cd, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491572, encodeId=aedb4915e283, content=还有谁投过，上来讲讲啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 22 09:08:00 CST 2012, time=2012-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487907, encodeId=c9ff48e9075b, content=审稿比较快！3月22日投稿后即显示under review，4月4号送审，4月11号告知被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee9f60163, createdName=wanglijun519, createdTime=Wed Apr 11 11:14:00 CST 2012, time=2012-04-11, status=1, ipAttribution=)]

2012-11-22 匿名用户

还有谁投过，上来讲讲啊？

414 0

[GetPortalCommentsPageByObjectIdResponse(id=561624, encodeId=ced356162431, content=氧化应激150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, beContent=150****7326(暂无匿称) 2018-09-26 00:00:00 发表: 你好，你写的是哪方面的内容, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Mon Oct 01 00:00:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561469, encodeId=66c356146980, content=你好，你写的是哪方面的内容150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～150****6990 2018-08-25 00:00:00 发表: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=150****6990 2018-08-25 发表:: 6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f80b1635617, createdName=1dd92ec0m26(暂无匿称), createdTime=Wed Sep 26 00:00:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560443, encodeId=01c6560443e8, content=6.18投稿，7.31初审意见-小修，8.22修回，8.24接受～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2eb82067893, createdName=1501ef7333m, createdTime=Sat Aug 25 00:00:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554917, encodeId=c77955491efc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2017年6月27号投稿 投的2型糖尿病方面的meta分析 2017年8月16号小修 2017年9月3号修回，18号接受，历时不到3个月。 总体来说，不难，升3分以上有难度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Sx9eFkIoYXS51HXxUcZoVsNzMFRK6sPjs4WW9QTp0aQJy4wszSAUHrPPBZ3zu8cGBZ1A5uoN4HMS4xYu55VfQ/132, createdBy=a55e2060721, createdName=sherry me, createdTime=Thu Apr 12 21:51:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547968, encodeId=382354e96815, content=请问大神们，版面费的情况？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Fri Oct 06 21:45:00 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538975, encodeId=777e5389e55f, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531433, encodeId=da045314331e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：非常幸运，由于准备比较充分，研究内容很切合杂志要求，所以投稿比较顺利。11.3号投稿后，12.8号修回，12.20号返修后1周接收。在2016年年底接收，算是为自己一年的努力画上了一个圆满的小句号。感悟：投稿前认真分析杂志的需求，文稿一定要认真修改好再投，当然审稿人没有提太多苛刻的问题也是一个重要的因素。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20ef96448, createdName=haoyaxin, createdTime=Wed Jan 04 17:02:00 CST 2017, time=2017-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492604, encodeId=c581492604cd, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491572, encodeId=aedb4915e283, content=还有谁投过，上来讲讲啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 22 09:08:00 CST 2012, time=2012-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487907, encodeId=c9ff48e9075b, content=审稿比较快！3月22日投稿后即显示under review，4月4号送审，4月11号告知被拒！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee9f60163, createdName=wanglijun519, createdTime=Wed Apr 11 11:14:00 CST 2012, time=2012-04-11, status=1, ipAttribution=)]

2012-04-11 wanglijun519

审稿比较快！3月22日投稿后即显示under review，4月4号送审，4月11号告知被拒！

382 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务